US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 3.0300
  • +0.1300+4.48%
Close Nov 22 16:00 ET
  • 3.1699
  • +0.1399+4.62%
Post 19:17 ET
44.70MMarket Cap0.89P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VYNE Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 100.000K --
-- 2024/Q4 -- / 140.000K --
-- 2024/Q3 121.000K / 110.000K --
-- 2024/Q2 198.000K / 110.000K --
-- 2024/Q1 98.000K / 100.000K --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 140.000K--
--2024/Q3121.000K / 110.000K--
--2024/Q2198.000K / 110.000K--
--2024/Q198.000K / 100.000K--

Unlock Free Earnings Estimates

VYNE Therapeutics Earnings Reports

  • VYNE Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:14

  • VYNE Therapeutics | 8-K: VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7 21:08

  • VYNE Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 15 04:53

  • VYNE Therapeutics | 8-K: VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 14 20:09

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data